KR920017648A - 피부 위측증의 경감 - Google Patents

피부 위측증의 경감 Download PDF

Info

Publication number
KR920017648A
KR920017648A KR1019920004212A KR920004212A KR920017648A KR 920017648 A KR920017648 A KR 920017648A KR 1019920004212 A KR1019920004212 A KR 1019920004212A KR 920004212 A KR920004212 A KR 920004212A KR 920017648 A KR920017648 A KR 920017648A
Authority
KR
South Korea
Prior art keywords
skin
composition
salt
steroid
hydroxy acid
Prior art date
Application number
KR1019920004212A
Other languages
English (en)
Other versions
KR100193993B1 (ko
Inventor
파랍 프라카쉬
라브커 로버트
레이든 제임스
Original Assignee
도미닉 엠. 메짜펠
브리스톨-마이어즈 스퀴브 컴패니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 도미닉 엠. 메짜펠, 브리스톨-마이어즈 스퀴브 컴패니 filed Critical 도미닉 엠. 메짜펠
Publication of KR920017648A publication Critical patent/KR920017648A/ko
Application granted granted Critical
Publication of KR100193993B1 publication Critical patent/KR100193993B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음

Description

피부 위측증의 경감
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (16)

  1. 유효성분으로서 C3-7알파 히드록시산의 염을 함유함을 특징으로 하는 스테로이드의 국소 사용에 관련된 피부 위축증 치료용 조성물.
  2. 제1항에 있어서, 염이 총 조성물 중량에 대해 약 1중량% 내지 약 53중량%의 양으로 존재하는 것이 특징인 조성물.
  3. 제2항에 있어서, 염이 암모늄염인 것이 특징인 조성물.
  4. 제3항에 있어서, 염이 암모늄 락테이트인 것이 특징인 조성물.
  5. 제2항에 있어서, 약 0.005중량% 내지 약 3중량%의 스테로이드를 추가로 함유하는 것이 특징인 조성물.
  6. 제4항에 있어서, 약 0.01중량% 내지 약 1.0중량%의 스테로이드를 추가로 함유하는 것이 특징인 조성물.
  7. 스테로이드 국소 사용과 관련된 피부 위측증의 치료에 있어서 상기의 위측된 피부를 C3-7알파 히드록시산의 염을 치료 유효량 함유하는 조성물과 접촉시키는 단계로 됨을 특징으로 하는 스테로이드 국소 사용관련 피부 위축증의 치료방법.
  8. 제7항에 있어서, 염이 총 조성물 중량에 기초하여 약2중량% 내지 약38중량%의 양으로 존재하는 것이 특징인 방법.
  9. 제8항에 있어서, 염이 암모늄염인 것이 특징인 방법.
  10. 제9항에 있어서, 염이 암모늄 락테이트인 것이 특징인 방법.
  11. C3-7알파 히드록시산의 염을 유효량 함유하는 피부 비후용 조성물에 피부를 접촉시키는 것으로 됨을 특징으로 하는 피부 비후화 방법.
  12. 제11항에 있어서, 피부 비후용 조성물을 적용하기전, 별도 단계에서 스테로이드를 피부에 적용시키는 것이 특징인 방법.
  13. 제11항에 있어서, 피부 비후용 조성물을 적용한 후, 별도단계에서 스테로이드를 피부에 적용시키는 것이 특징인 방법.
  14. C3-7알파 히드록시산의 염을 유효량 함유하는 조성물에 대상자의 피부를 접촉시키는 것으로 됨을 특징으로 하는 생육가능한 표피중의 기저 물질을 증가시키는 방법.
  15. 제14항에 있어서, 히드록시산-함유 조성물을 적용하기 전, 별도단계에서 스태로이드를 피부에 적용시키는 것이 특징인 방법.
  16. 제14항에 있어서, 히드록시산-함유 조성물을 적용한 후, 별도단계에서 스테로이드를 피부에 적용시키는 것이 특징인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920004212A 1991-03-19 1992-03-14 피부 위축증의 경감용 조성물 KR100193993B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67157791A 1991-03-19 1991-03-19
US671,577 1991-03-19

Publications (2)

Publication Number Publication Date
KR920017648A true KR920017648A (ko) 1992-10-21
KR100193993B1 KR100193993B1 (ko) 1999-06-15

Family

ID=24695083

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920004212A KR100193993B1 (ko) 1991-03-19 1992-03-14 피부 위축증의 경감용 조성물

Country Status (16)

Country Link
US (2) US5254343A (ko)
EP (1) EP0504862B1 (ko)
JP (1) JP3504279B2 (ko)
KR (1) KR100193993B1 (ko)
AT (1) ATE141050T1 (ko)
AU (1) AU655005B2 (ko)
CA (1) CA2063127C (ko)
DE (1) DE69212610T2 (ko)
DK (1) DK0504862T3 (ko)
ES (1) ES2090390T3 (ko)
GR (1) GR3020779T3 (ko)
HK (1) HK1004532A1 (ko)
IE (1) IE920859A1 (ko)
SG (2) SG79901A1 (ko)
TW (1) TW208658B (ko)
ZA (1) ZA921821B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy
CA2143515A1 (en) * 1994-03-22 1995-09-23 Prakash Parab Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer
US5420106A (en) * 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US5683705A (en) * 1996-03-29 1997-11-04 Estee Lauder, Inc. Sulfur-based amides and bis-amides useful against skin disorders
US5993792A (en) * 1997-11-13 1999-11-30 Tiro Industries Incorporated System for customized hair products containing surfactants
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
JP2004537506A (ja) 2001-03-01 2004-12-16 ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド 血液細胞欠乏症を治療するためのある種のステロイドの使用
AU2002314847A1 (en) 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
EP2298316A1 (en) 2002-08-28 2011-03-23 Harbor BioSciences, Inc. Therapeutic treatment methods
AU2005330504B2 (en) 2004-09-29 2010-10-28 Harbor Biosciences, Inc. Steroid analogs and characterization and treatment methods
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
DE102014209988A1 (de) * 2014-05-26 2015-11-26 Deb Ip Limited Aluminiumlactat als Hautschutzkomponente

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4380549A (en) * 1975-07-23 1983-04-19 Scott Eugene J Van Topical treatment of dry skin
PH13782A (en) * 1976-09-07 1980-09-26 E Scott Therapeutic treatment of dry skin
US4246261A (en) * 1979-08-09 1981-01-20 Scott Eugene J Van Additives enhancing topical corticosteroid action
US4485091A (en) * 1980-07-15 1984-11-27 Quinoderm Limited Dermatological compositions
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US4937068A (en) * 1988-10-31 1990-06-26 Jim Baral Sun tanning medication and treatment
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy

Also Published As

Publication number Publication date
KR100193993B1 (ko) 1999-06-15
US5807600A (en) 1998-09-15
SG141206A1 (en) 2008-04-28
DK0504862T3 (da) 1996-09-02
US5254343A (en) 1993-10-19
GR3020779T3 (en) 1996-11-30
AU655005B2 (en) 1994-12-01
HK1004532A1 (en) 1998-11-27
EP0504862A1 (en) 1992-09-23
ZA921821B (en) 1993-01-27
DE69212610T2 (de) 1997-03-27
AU1295592A (en) 1992-09-24
ATE141050T1 (de) 1996-08-15
JPH05117144A (ja) 1993-05-14
ES2090390T3 (es) 1996-10-16
IE920859A1 (en) 1992-09-23
JP3504279B2 (ja) 2004-03-08
SG79901A1 (en) 2001-04-17
TW208658B (ko) 1993-07-01
CA2063127A1 (en) 1992-09-20
DE69212610D1 (de) 1996-09-12
EP0504862B1 (en) 1996-08-07
CA2063127C (en) 2002-01-29

Similar Documents

Publication Publication Date Title
KR920017648A (ko) 피부 위측증의 경감
US4997853A (en) Method and compositions utilizing capsaicin as an external analgesic
US3984566A (en) Method of alleviating the symptoms of dandruff
US3988470A (en) Treatment of palmar and plant disturbed keratosis
KR880000091A (ko) 국소용 약제학적 조성물 이의 제조방법 및 이의 용도
Aggarwal et al. A Clinical Trial with'cotaryl Cream'in Hyperkeratotic Skin Conditions
ES2053882T3 (es) Metodo para reducir la irritacion de la piel asociado con composiciones potenciadoras de penetracion del farmaco.
IE43241L (en) Vehicle composition containing azacycloalkan-2-ones
BR9916450A (pt) Composição tópica, método cosmético para tratar e/ ou prevenir condições de pele, e, uso de ácido linoleico conjugado, e/ ou derivados do mesmo
BR8906716A (pt) Processo para preparar uma composicao preservada,processo para converto o cabelo de crescimento junto ao couro cabeludo em cabelo de crescimento terminal e processo para aumentar a velocidade de crescimento de cabelo terminal
CA2144509A1 (en) Skin-conditioning composition, its application and manufacture
BR9803281A (pt) Composição contendo hidróxi-ácido e reinóide; e; processo cosmético para reduzir picada ou irritação induzida pela aplicação local de uma composição contendo um hidróxi-ácido ou um retinóide.
GB2058563A (en) Topical triethylenetetramine pharmaceutical compositions
DE69428295D1 (de) Perkutane Behandlung mit Mastzelldegranulatoren zur Behandlung von Reizstoffüberempfindlichkeit
CY1108934T1 (el) Τοπικες συνθεσεις οι οποιες συνδυαζουν κλασματα υαλουρονικου νατριου και ενα ρετινοειδες
NO304727B1 (no) Anvendelse av et retinoid til fremstilling av et topisk preparat for behanding av cellulitt
RU94015599A (ru) Применение n - ацетил-l - цистеина и его производных для регулирования образования морщин кожи и/или атрофии кожи, композиция на основе n - ацетил - l - цистеина и его производных
MX2022008844A (es) Una composicion topica que comprende acido hidroxamico y atractilenolida.
ES8206974A1 (es) Un procedimiento para preparar una composicion farmaceutica para aplicacion topica, empleada en el tratamiento del acne.
BR9106124A (pt) Composicao parasiticida para aplicacao topica e processo de controlar a infestacao de ectoparasitas em hospedeiros mamiferos,domesticos,nao humanos
JPH0680038B2 (ja) 安定化された透明過酸化ベンゾイル組成物
KR890701113A (ko) 신규한 국소용 메트로니다졸 제제 및 이의 치료학적 용도
KR950031085A (ko) 표피증식 질환 치료용 의약 조성물
Statham et al. Short‐contact dithranol therapy—a comparison with the Ingram regime
KR880002518A (ko) 소염제 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20110207

Year of fee payment: 13

EXPY Expiration of term